LINEX

This brand name is authorized in Lithuania

Active ingredients

The drug LINEX contains a combination of these active pharmaceutical ingredients (APIs):

1 Lactobacillus acidophilus (sp. L.gasseri)
UNII 1PRR1V42V5 - LACTOBACILLUS ACIDOPHILUS
Read about Lactic acid bacteria
2 Lactic acid bacteria
UNII EF3U3H7I76 - BIFIDOBACTERIUM LONGUM INFANTIS
Read about Lactic acid bacteria
3 Lactic acid bacteria
UNII 34YYS7G16P - ENTEROCOCCUS FAECIUM
Read about Lactic acid bacteria

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A07FA51 Lactic acid producing organisms, combinations A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07F Antidiarrheal microorganisms → A07FA Antidiarrheal microorganisms
Discover more medicines within A07FA51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: LT Valstybinฤ— vaistลณ kontrolฤ—s tarnyba Identifier(s): 1006814, 1026923

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈